A major advance in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant suppressor protein is frequently disabled in several forms of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research